A randomized controlled trial to determine whether beta-hydroxy-beta-methylbutyrate and/or eicosapentaenoic acid improves diaphragm and quadriceps strength in critically Ill mechanically ventilated patients

BACKGROUND: Intensive care unit acquired weakness is a serious problem, contributing to respiratory failure and reductions in ambulation. Currently, there is no pharmacological therapy for this condition. Studies indicate, however, that both beta-hydroxy-beta-methylbutyrate (HMB) and eicosapentaenoi...

Descripción completa

Detalles Bibliográficos
Autores principales: Supinski, Gerald S., Netzel, Paul F., Westgate, Philip M., Schroder, Elizabeth A., Wang, Lin, Callahan, Leigh Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390080/
https://www.ncbi.nlm.nih.gov/pubmed/34446067
http://dx.doi.org/10.1186/s13054-021-03737-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390080/
https://www.ncbi.nlm.nih.gov/pubmed/34446067
http://dx.doi.org/10.1186/s13054-021-03737-9

Ejemplares similares